Scalper1 News
In the field of biotech investing, venture capitalist James Blair is one of the veterans. Working at Rothschild back in the 1980s, Blair was an early investor in Applied Biosystems — now part of Thermo Fisher Scientific (TMO) — which developed the gene sequencers used in the Human Genome Project. He was also an early player in Amgen (AMGN), one of the first companies to use genetic information to hit it big in the drug industry. Since then, he’s Scalper1 News
Scalper1 News